IL13 and Alzheimer disease: Th2 and Th17 cells (IL-4/IL-13 and IL-17/IL-22, respectively) produce cytokines that inhibit terminal differentiation of epidermis and contribute to the rupture of the epithelial barrier in AD patients [1,2,4].